developed blindness or had seriously visual impairment at the time when we collected the biological samples. Blood samples from nine patients and six normal individuals (each 3 ml) from the three families were collected by using vacuum blood collection tubes with K 2 EDTA, and stored at -20 °C prior to use. Written informed consent conforming to the tenets of the Declaration of Helsinki was obtained from each participant before the study was conducted. The institutional review board of the Kunming Institute of Zoology approved this study.
Clinical examinations: Physical measurements for each family member were performed following the World Health Organization Multinational Monitoring of Trends and Genetic analysis: Genomic DNAs were isolated from the whole blood of all examined individuals from the three families by using the AxyPrep Blood Genomic DNA Miniprep Kit (Axygen Biosciences, Union City, CA). We also isolated genomic DNA using the same approach from the whole blood of 196 unrelated healthy individuals from Yunnan Province who attended regular medical examinations. Three pairs of primers were designed to amplify and sequence four exons of the TTR gene in all examined family members ( software was used to predict whether the TTR mutation could change protein structure. In addition, we determined the mitochondrial DNA (mtDNA) haplogroup status of each maternally unrelated patient using the methods described in our previous study [20] to discern potential maternal kinship among the three families. In brief, each sample was amplified and analyzed for a 1.4 kb fragment (region 16024-850) that covers the entire mtDNA control region and was classified on the basis of haplogroup motif and (near-)matching with reported Chinese. The clinical phenotypes and examination results were similar in the three families. Though some patients in the three families, such as II:7 in Family A and the probands in Family B (III:21) and Family C (III:7), were older, they did not express any abnormality in other organs/tissues. The visual acuity of the patients ranged from light perception to 1.2 before surgery (Table 1) , but the intraocular pressure was normal in all patients. Amyloidosis and high echoes were identified with the slit-lamp photograph test and B-mode ultrasonography (Figure 2 ), respectively. The results for the visual evoked potential test, retinal vessels, electroretinogram, and other routine measurements were normal in all patients. Eyesight of all patients was rescued after vitrectomy and gas tamponade. Pathological examination of Congo red staining showed amyloid deposition in the vitreous body of all probands (Figure 2 ). Other physical examinations, including routine blood tests and biochemical tests, urine routine examination, liver function test, kidney function tests, chest X-rays, electrocardiograph, and the examinations of peripheral nerve system revealed no potential dysfunction of these organs in the probands. 
RESULTS

Clinical features of three
Presence of the same transthyretin mutation p.G83R in three families:
We amplified and sequenced the most common candidate gene, the TTR gene, and detected only a rare missense heterozygous mutation c.307G>C (p.G83R) in exon 3 of the probands of the three families ( Figure 3A) . After screening this mutation in all collected subjects from the three families and 196 unrelated healthy controls, we found that all patients, but not the normal controls (excluding individuals III:27 and IV:20 in Family B who had no ophthalmological or other symptoms but had mutation c.307G>C), harbored this mutation. Conservation analysis of ten vertebrate species indicated this rare mutation changed a highly conserved glycine to arginine in position 83 of the TTR protein ( Figure  3B ). As shown in Figure 4 , the predicted three-dimensional structure of the TTR protein was changed by p.G83R. mtDNA analysis of five maternally unrelated patients from the three families suggested that they belonged to different mtDNA haplogroups (Table 3) 
DISCUSSION
Though familial amyloidotic polyneuropathy occurs and is distributed worldwide, most cases have been reported in Japan, Portugal, and Sweden [21] [22] [23] . Some patients with FAP express complex clinical features, and the most frequently impaired tissue is the peripheral nerve system [24] . However, several patients experienced only decreasing eyesight and vitreous amyloidosis [2, 25] . Here we reported three Chinese families with vitreous amyloidosis and the same rare heterozygous mutation p.G83R in the TTR protein. The affected members in Family A presented progressive visual disturbance in their 30s; the patients in Family B and Family C had visual failure in their 40s. All patients in the three families expressed only visual impairment, and their eyesight was rescued after ophthalmologic surgery.
Most of the cases of FAP are caused by a common mutation p.V30M of the TTR protein, and only a few have been caused by other rare mutations [8] . The mutant spectra of the TTR protein are diversiform in different populations [5] . In this study, the patients from the three Chinese families harbored the same mutation p.G83R. Intriguingly, this mutation was previously reported in three Chinese families with vitreous amyloidosis [16, 26] (note that one of the two families reported in [26] was first reported in [27] , but this was not mentioned in their later paper [26] ; mutation p.G83R was named p.G103R in the family reported in [16] ). Similar to our study, there are no other clinical features excluding decreasing vision and vitreous amyloidosis in the probands of these three reported Chinese families [16, 26] . A search for literature identified three more Chinese families with HVA with different TTR mutations (p. K35Y and p.L55R were reported in [11] ; p.R54G was reported in [14] ). Evidently, mutant p.G83R is common in Chinese patients with HVA (six occurrences in nine families), similar to mutant p.V30M in patients with FAP. More Chinese patients with HVA, even sporadic cases of vitreous amyloidosis, should be screened to validate this pattern.
We determined the mtDNA background and haplogroups of five patients from the three families and excluded the possibility of potential maternal kinship among these families. This result suggests that mutation p.G83R might occur independently in the three families. The seemingly common distribution of this mutation in Han Chinese with HVA may be used for clinical diagnosis. Two individuals with c.307G>C (III:27 and IV:20) in Family B did not express any symptoms at the time of analysis. As these two individuals were younger than the average age of onset of the other patients in Family B, we speculate that the clinical onset of HVA is influenced by age, at least for members in this family. Detection of the mutation in these normal members may offer insight into early protection and prevention treatments. Conservative evolution analysis indicated that mutation p.G83R occurs in a highly conserved position and might impair the protein structure and function ( Figure 4) . We have speculated that the presence of mutation p.G83R might impair the tertiary structure of the TTR protein, leading to production of insoluble aggregates of the mutant protein [28] . Further experimental analyses should be performed to confirm the predicted pathogenicity of mutant p.G83R. Moreover, it is worth clarifying why the TTR mutant p.G83R influences only the vitreous body but not other tissues and how this mutation causes the disorder.
In short, we reported three Chinese families with HVA and mutation c.307G>C (p.G83R) in the TTR gene. Our study indicated that TTR mutant p.G83R might be a common pathogenic mutation in Chinese patients with HVA. Examining more families with HVA and functional characterization of mutant p.G83R is essential to further confirm our findings. 
